Pharmatrans MCC SANAQ® S – Advancing Pharmaceutical Formulations with Silicified Microcrystalline Cellulose

Pharmatrans’ Microcrystalline Cellulose MCC SANAQ® S represents a groundbreaking advancement in the field of pharmaceutical excipients. MCC SANAQ® S is a highly multifunctional excipient that combines microcrystalline cellulose (MCC) and colloidal silicon dioxide (CSD).

MCC Silicified Sanaq can solve problems related to powder mixtures such as inefficient compatibility, blending issues and limited binding properties in oral solid dosage (OSD) formulations.

Furthermore, it can be used for direct compression, significantly reducing the number of required excipients and manufacturing costs, leading to more cost-effective tablet production.

MCC SANAQ® S characteristics

The combination of MCC and CSD makes MCC SANAQ® S easy to use in formulations, with highly advantageous compaction and flowability characteristics. Additionally, it exhibits plastic deformation characteristics, giving it superior binding properties.

The product is obtained by a spray drying process, giving it greater homogeneity, a much narrower CSD particle size distribution, and higher surface area. The increased surface area enabled by CSD coating of the MCC particles enables superior flow and increased compaction and results in improved content uniformity and stability in the formulation, even for low dosage formulations or for micronized APIs.

MCC SANAQ® S benefits

These characteristics make MCC SANAQ® S a genuinely multifunctional excipient that is easy to use and that can impart optimum compaction and excellent flowability to the powder mixed for compression.

MCC Silicified Sanaq delivers a series of benefits for formulators, including:

• Enhanced drug loading (up to 50% API)
• Cost reductions and patient convenience from smaller tablet size
• Enhanced powder flow for high speed tableting
• Improved lubrication efficiency
• Tablet hardness and reduced friability at lower compression pressures
• Greater homogeneity and content uniformity

The Pharmatrans Advantage

Versatility Tailor your formulations to perfection with MCC SANAQ® S. Whether you’re dealing with complex APIs or demanding manufacturing conditions, Pharmatrans’ excipient adapts to meet your needs.

Consistency Rely on uniform performance across every batch. MCC SANAQ® S ensures consistent quality, making it a reliable partner in your production line.

Cost Efficiency Maximize your investment with MCC SANAQ® S. Reduced waste, fewer defects, and lower maintenance costs translate into significant savings and higher profitability.

Pharmatrans’ MCC SANAQ® S stands out as a cutting-edge excipient that addresses many of the challenges faced in modern pharmaceutical manufacturing. Its combination of microcrystalline cellulose and silicon dioxide offers a robust solution for improving the flowability and compressibility of tablet formulations.

Pharmaceutical companies can benefit from the enhanced performance, versatility, and cost-efficiency of MCC SANAQ® S. MCC SANAQ® S is the formulator’s friend when it comes to a multifunctional excipient that is easy to use and enables more rapid tablet development and enhanced production outputs.

For more information and to place your order, visit our website or contact our sales team.

Experience the difference with MCC SANAQ® S – your ultimate solution for superior tablet formulation.

Resources

Click on MCC SANAQ® S specifications for detailed data.